Evidence map›Paper›PMID 31228949›Full record

ArticleJournal of ovarian research2019

Decellularization of the mouse ovary: comparison of different scaffold generation protocols for future ovarian bioengineering.

Ahmed Baker Alshaikh, Arvind Manikantan Padma, Matilda Dehlin, Randa Akouri, Min Jong Song, Mats Brännström, Mats Hellström

Open access · goldAbstract readComparative Study
In one paragraph

Article in Journal of ovarian research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Prospects for use of bioengineered tissue from stem cells in gynecology.Acta obstetricia et gynecologica Scandinavica · 2023
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ahmed Baker AlshaikhLaboratory for Transplantation and Regenerative Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Arvind Manikantan PadmaLaboratory for Transplantation and Regenerative Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Matilda DehlinLaboratory for Transplantation and Regenerative Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Randa AkouriLaboratory for Transplantation and Regenerative Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Min Jong SongLaboratory for Transplantation and Regenerative Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Mats BrännströmLaboratory for Transplantation and Regenerative Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Mats HellströmLaboratory for Transplantation and Regenerative Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. mats.hellstrom@gu.se.ORCID http://orcid.org/0000-0003-3323-5618
University of Gothenburg · SEStockholm IVF · SEThe Catholic University of Korea Daejeon St. Mary's Hospital · KR

Funding

Adlerbertska Stiftelserna N/AStiftelsen Handlanden Hjalmar Svenssons N/AStiftelserna Wilhelm och Martina Lundgrens N/AVetenskapsrådet 116008
6 · The paper itself

Abstract

backgroundIn order to preserve fertility in young women with disseminated cancer, e.g. leukemia, an approach that has been suggested is to retransplant isolated small follicles within an ovarian matrix free from malignant cells and with no risk for contamination. The present study evaluates the first step to create a bioengineered ovarian construct that can act as growth-supporting tissue for isolated small follicles that are dependent on a stroma for normal follicular maturation. The present study used the intact mouse ovary to develop a mouse ovarian scaffold through various protocols of decellularization. MATERIAL AND

methodsPotential Immunogenic DNA and intracellular components were removed from whole mouse ovaries by agitation in a 0.5% sodium dodecyl sulfate solution (Protocol 1; P1), or in a 2% sodium deoxycholate solution (P2) or by a combination of the two (P3). The remaining decelluralized ovarian extracellular matrix structure was then assessed based on the DNA- and protein content, and was further evaluated histologically by haematoxylin and eosin-, Verhoeff's van gieson- (for elastin), Masson's trichrome- (for collagens) and Alcian blue (for glycosaminoglycans) staining. We also evaluated the decellularization efficiency using the mild detergent Triton-X100 (1%).

resultsSodium dodecyl sulfate efficiently removed DNA and intracellular components from the ovarian tissue but also significantly reduced the integrity of the remaining ovarian extracellular matrix. Sodium deoxycholate, a considerably milder detergent compared to sodium dodecyl sulfate, preserved the ovarian extracellular matrix better, evident by a more distinct staining for glycosaminoglycan, collagen and elastic fibres. Triton-X100 was found ineffective as a decellularization reagent for mouse ovaries in our settings.

conclusionsThe sodium dodecyl sulfate generated ovarian scaffolds contained minute amounts of DNA that may be an advantage to evade a detrimental immune response following engraftment. The sodium deoxycholate generated ovarian scaffolds had higher donor DNA content, yet, retained the extracellular composition better and may therefore have improved recellularization and other downstream bioengineering applications. These two novel types of mouse ovarian scaffolds serve as promising scaffold-candidates for future ovarian bioengineering experiments.

Indexed as

Tissue ScaffoldsAnimalsBioartificial OrgansDeoxycholic AcidDNAExtracellular MatrixFemaleMiceMice, Inbred C57BLOvarySodium Dodecyl SulfateTissue EngineeringDeoxycholic AcidDNASodium Dodecyl SulfateBiomaterialDecellularizationExtracellular matrixMalignancyOvaryScaffoldTissue engineering

Identifiers

PMID31228949
PMCPMC6588934
OpenAlexW2950786364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.